Free Trial

Camden National (CAC) Financials

Camden National logo
$49.30 +0.68 (+1.40%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$49.30 0.00 (0.00%)
As of 05/8/2026 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Camden National

Annual Income Statements for Camden National

This table shows Camden National's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
21 40 28 53 57 59 69 61 43 53 65
Consolidated Net Income / (Loss)
21 40 28 53 57 59 69 61 43 53 65
Net Income / (Loss) Continuing Operations
21 40 28 53 57 59 69 61 43 53 65
Total Pre-Tax Income
31 58 62 66 72 74 87 77 54 65 79
Total Revenue
114 153 154 159 170 187 187 188 163 177 256
Net Interest Income / (Expense)
86 113 115 120 128 136 137 148 132 132 203
Total Interest Income
99 130 136 151 169 157 148 173 226 250 321
Loans and Leases Interest Income
81 109 115 129 143 134 125 145 195 215 273
Investment Securities Interest Income
17 20 21 22 23 22 22 28 28 31 45
Federal Funds Sold and Securities Borrowed Interest Income
0.62 0.48 0.76 1.14 2.19 0.89 0.77 - 2.61 4.05 2.92
Total Interest Expense
13 17 21 31 41 21 11 25 94 117 117
Deposits Interest Expense
6.51 8.63 12 20 34 16 7.92 20 79 96 97
Long-Term Debt Interest Expense
6.18 7.92 8.99 11 6.89 5.35 3.13 4.79 15 21 20
Total Non-Interest Income
27 40 39 38 42 50 50 41 31 45 53
Other Service Charges
21 32 35 13 40 48 47 40 39 42 49
Net Realized & Unrealized Capital Gains on Investments
0.00 0.05 0.86 0.28 -0.11 0.00 0.00 -0.91 -10 0.00 0.00
Other Non-Interest Income
1.68 2.59 2.37 25 2.43 2.53 2.36 1.90 2.35 2.81 3.44
Provision for Credit Losses
1.94 5.26 3.04 0.85 2.86 12 -3.19 4.50 2.10 -0.40 22
Total Non-Interest Expense
81 90 89 92 95 100 104 107 107 112 155
Salaries and Employee Benefits
37 47 49 52 54 58 61 62 60 64 80
Net Occupancy & Equipment Expense
14 17 17 17 18 19 20 21 21 22 29
Other Operating Expenses
18 23 21 22 22 22 22 24 26 24 31
Amortization Expense
1.31 1.90 1.80 0.73 0.71 0.68 0.66 0.63 0.59 0.56 5.89
Restructuring Charge
10 0.87 - - - - - 0.00 0.00 1.16 9.29
Income Tax Expense
9.91 17 34 13 14 15 18 16 10 12 13
Basic Earnings per Share
$1.73 $2.59 $1.83 $3.40 $3.70 $3.96 $4.62 $4.18 $2.98 $3.63 $3.86
Weighted Average Basic Shares Outstanding
12.03M 15.42M 15.51M 15.57M 15.41M 14.99M 14.90M 14.64M 14.56M 14.58M 16.90M
Diluted Earnings per Share
$1.73 $2.57 $1.82 $3.39 $3.69 $3.95 $4.60 $4.17 $2.97 $3.62 $3.84
Weighted Average Diluted Shares Outstanding
12.07M 15.50M 15.59M 15.63M 15.45M 15.02M 14.97M 14.70M 14.61M 14.63M 16.98M
Weighted Average Basic & Diluted Shares Outstanding
12.10M 15.50M 15.60M 15.60M 15.50M 14.91M 14.74M 14.57M 14.57M 16.86M 16.93M
Cash Dividends to Common per Share
$1.20 $0.83 $0.94 $1.15 $1.23 $1.32 $1.48 $1.62 $1.68 $1.68 $1.68

Quarterly Income Statements for Camden National

This table shows Camden National's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
9.79 8.48 13 12 13 15 7.33 14 21 23 22
Consolidated Net Income / (Loss)
9.79 8.48 13 12 13 15 7.33 14 21 23 22
Net Income / (Loss) Continuing Operations
9.79 8.48 13 12 13 15 7.33 14 21 23 22
Total Pre-Tax Income
12 10 16 15 16 18 6.17 18 26 28 28
Total Revenue
38 39 42 43 45 48 60 62 65 68 64
Net Interest Income / (Expense)
33 33 31 32 34 35 49 49 51 54 52
Total Interest Income
58 60 60 62 64 63 78 79 81 82 78
Loans and Leases Interest Income
50 51 52 53 55 54 67 67 69 70 67
Investment Securities Interest Income
6.86 10 7.80 7.79 7.47 12 11 11 11 11 11
Federal Funds Sold and Securities Borrowed Interest Income
0.69 - 0.67 0.95 0.76 - 1.09 0.64 0.58 0.61 0.53
Total Interest Expense
25 27 29 30 30 28 30 30 30 28 26
Deposits Interest Expense
21 23 23 24 25 23 25 25 25 23 22
Long-Term Debt Interest Expense
4.12 4.25 5.73 5.81 5.08 4.67 4.92 5.52 4.90 4.77 4.37
Total Non-Interest Income
5.07 5.99 10 11 11 12 11 13 14 14 12
Other Service Charges
9.76 -17 9.64 9.95 11 11 11 12 13 13 11
Other Non-Interest Income
0.64 28 0.68 0.69 0.71 0.72 0.66 1.00 0.96 0.82 0.79
Provision for Credit Losses
-0.57 0.57 -2.10 0.65 0.24 0.81 9.43 6.92 2.97 2.97 0.55
Total Non-Interest Expense
26 28 27 27 29 28 44 38 36 37 36
Salaries and Employee Benefits
15 15 16 16 17 16 20 19 20 20 20
Net Occupancy & Equipment Expense
5.19 5.54 5.70 5.48 5.47 5.63 7.76 6.99 6.84 7.37 7.70
Other Operating Expenses
6.13 6.75 5.57 6.09 6.02 6.19 7.45 8.34 7.21 7.90 7.04
Amortization Expense
0.15 0.15 0.14 0.14 0.14 0.14 1.47 1.47 1.47 1.47 1.35
Restructuring Charge
0.00 - 0.00 0.00 0.73 - 7.53 1.41 0.32 0.04 0.00
Income Tax Expense
2.24 1.80 3.06 2.88 2.78 3.74 -1.15 3.68 5.30 5.66 6.19
Basic Earnings per Share
$0.67 $0.59 $0.91 $0.82 $0.90 $1.00 $0.43 $0.84 $1.25 $1.34 $1.29
Weighted Average Basic Shares Outstanding
14.56M 14.56M 14.57M 14.59M 14.58M 14.58M 16.84M 16.91M 16.92M 16.90M 16.92M
Diluted Earnings per Share
$0.67 $0.58 $0.91 $0.81 $0.90 $1.00 $0.43 $0.83 $1.25 $1.33 $1.29
Weighted Average Diluted Shares Outstanding
14.60M 14.61M 14.63M 14.65M 14.65M 14.63M 16.93M 16.97M 17.01M 16.98M 17.02M
Weighted Average Basic & Diluted Shares Outstanding
14.56M 14.57M 14.61M 14.57M 14.58M 16.86M 16.90M 16.92M 16.92M 16.93M 16.91M
Cash Dividends to Common per Share
$0.42 $0.42 $0.42 $0.42 $0.42 $0.42 $0.42 $0.42 $0.42 $0.42 $0.42

Annual Cash Flow Statements for Camden National

This table details how cash moves in and out of Camden National's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
19 8.22 15 -36 8.64 70 75 -145 24 115 -117
Net Cash From Operating Activities
16 57 58 64 33 18 143 105 68 61 64
Net Cash From Continuing Operating Activities
16 57 58 64 33 18 143 105 68 61 64
Net Income / (Loss) Continuing Operations
21 40 28 53 57 59 69 61 43 53 65
Consolidated Net Income / (Loss)
21 40 28 53 57 59 69 61 43 53 65
Provision For Loan Losses
1.94 5.26 3.04 0.85 2.86 12 -3.19 4.50 2.10 -0.40 22
Depreciation Expense
3.25 4.43 3.76 3.77 3.89 3.83 3.71 3.49 3.37 3.31 5.21
Amortization Expense
3.55 5.04 4.92 3.93 3.70 5.49 7.38 4.46 2.90 2.34 7.67
Non-Cash Adjustments to Reconcile Net Income
-8.86 -7.91 5.65 3.12 -7.20 -30 36 5.29 9.37 2.34 -21
Changes in Operating Assets and Liabilities, net
-4.90 11 12 -0.40 -28 -33 30 26 6.38 0.35 -16
Net Cash From Investing Activities
-55 -168 -212 -277 -56 -294 -649 -488 -7.03 30 -56
Net Cash From Continuing Investing Activities
-55 -168 -212 -277 -56 -294 -649 -488 -7.03 30 -56
Purchase of Property, Leasehold Improvements and Equipment
-3.19 -1.67 -2.84 -5.02 -4.27 -2.93 -1.85 -2.18 -2.62 -5.58 -5.71
Purchase of Investment Securities
-270 -352 -365 -232 -339 -433 -759 -138 -137 -60 -240
Sale of Property, Leasehold Improvements and Equipment
0.00 0.09 0.14 0.75 - 0.00 0.00 0.47 0.00 0.00 3.19
Divestitures
60 - - - - - - - 0.00 0.00 48
Sale and/or Maturity of Investments
160 193 168 219 372 276 323 275 254 134 234
Other Investing Activities, net
-1.59 -7.34 -12 -259 -84 -134 -212 -623 -122 -37 -96
Net Cash From Financing Activities
58 119 169 176 32 346 581 237 -36 24 -125
Net Cash From Continuing Financing Activities
58 119 169 176 32 346 581 237 -36 24 -125
Net Change in Deposits
72 103 172 464 73 468 604 218 -230 36 -67
Issuance of Debt
24 77 37 0.00 0.00 25 49 54 220 375 17
Issuance of Common Equity
0.75 0.89 - - -0.20 -0.12 -0.26 -0.36 -0.26 -0.22 -0.54
Repayment of Debt
-29 -50 -25 -270 -2.17 -117 -40 -0.16 -0.17 -360 -45
Repurchase of Common Equity
- 0.00 -0.61 -0.38 -21 -9.69 -10 -10 -2.00 -1.61 0.00
Payment of Dividends
-9.79 -12 -14 -17 -19 -20 -21 -24 -25 -25 -28
Other Financing Activities, Net
-0.61 - - - - - - 0.00 0.00 -0.25 0.00
Cash Interest Paid
13 17 21 30 41 22 11 25 92 117 117
Cash Income Taxes Paid
12 11 17 11 14 16 19 13 11 8.82 6.15

Quarterly Cash Flow Statements for Camden National

This table details how cash moves in and out of Camden National's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
117 -112 77 -71 34 75 4.45 -106 -15 -1.36 36
Net Cash From Operating Activities
47 -11 18 14 -15 43 1.03 6.03 36 21 20
Net Cash From Continuing Operating Activities
47 -11 18 14 -15 43 1.03 6.03 36 21 20
Net Income / (Loss) Continuing Operations
9.79 8.48 13 12 13 15 7.33 14 21 23 22
Consolidated Net Income / (Loss)
9.79 8.48 13 12 13 15 7.33 14 21 23 22
Provision For Loan Losses
-0.57 0.57 -2.10 0.65 0.24 0.81 9.43 6.92 2.97 2.97 0.55
Depreciation Expense
0.82 0.91 0.82 0.82 0.82 0.86 1.51 1.32 1.20 1.18 1.27
Amortization Expense
2.58 -1.19 0.58 0.58 0.60 0.57 1.72 2.76 1.95 1.89 1.62
Non-Cash Adjustments to Reconcile Net Income
0.09 8.24 2.01 1.08 -8.21 1.55 -4.98 -16 9.93 -9.75 -4.24
Changes in Operating Assets and Liabilities, net
34 -28 3.19 -0.63 -21 25 -14 -2.56 -1.15 1.90 -1.07
Net Cash From Investing Activities
70 -29 -4.78 8.87 30 -3.55 62 -53 -82 17 46
Net Cash From Continuing Investing Activities
70 -29 -4.78 8.87 30 -3.55 62 -53 -82 17 46
Purchase of Property, Leasehold Improvements and Equipment
-0.70 -0.89 -0.55 -1.29 -1.71 -2.03 -1.76 -1.49 -0.69 -1.77 -1.78
Purchase of Investment Securities
44 -85 0.00 -19 20 -34 -81 -45 -44 -70 -3.10
Divestitures
- - 0.00 - - - 48 - - - 0.00
Sale and/or Maturity of Investments
87 93 28 34 36 36 96 43 45 51 52
Other Investing Activities, net
-60 -36 -32 -4.69 -24 -2.89 0.54 -49 -85 38 -0.91
Net Cash From Financing Activities
0.45 -72 64 -95 19 36 -59 -58 31 -39 -30
Net Cash From Continuing Financing Activities
0.45 -72 64 -95 19 36 -59 -58 31 -39 -30
Net Change in Deposits
-15 -81 -46 -38 61 58 -7.42 -83 -112 135 48
Issuance of Debt
22 15 251 6.11 134 119 -44 32 150 -167 -68
Issuance of Common Equity
- -0.08 0.07 - - -0.02 -0.15 -0.36 -0.01 -0.01 -0.35
Repayment of Debt
-0.04 -0.04 -135 -55 -170 -135 -0.20 -0.05 -0.05 -0.05 -0.20
Repurchase of Common Equity
0.17 - 0.00 -1.83 0.12 0.04 0.00 - - - -1.49
Payment of Dividends
-6.13 -6.13 -6.14 -6.14 -6.14 -6.14 -7.10 -7.12 -7.13 -7.13 -7.13
Cash Interest Paid
25 27 29 30 30 28 29 30 30 28 26
Cash Income Taxes Paid
3.95 2.30 0.10 5.16 3.34 0.23 0.13 0.86 2.66 2.52 0.23

Annual Balance Sheets for Camden National

This table presents Camden National's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
3,709 3,864 4,065 4,297 4,430 4,899 5,500 5,672 5,715 5,805 6,975
Cash and Due from Banks
79 52 44 52 40 50 39 51 78 62 72
Interest Bearing Deposits at Other Banks
- 36 59 15 36 96 182 25 22 153 26
Trading Account Securities
834 874 884 912 923 1,121 1,513 1,246 1,175 1,117 1,421
Loans and Leases, Net of Allowance
2,469 2,571 2,758 3,002 3,070 3,182 3,398 3,973 4,061 4,080 4,920
Loans and Leases
2,490 2,595 2,782 3,026 3,095 3,220 3,431 4,010 4,098 4,115 4,965
Allowance for Loan and Lease Losses
21 23 24 25 25 38 33 37 37 36 45
Loans Held for Sale
11 15 8.10 4.40 12 42 3,404 5.20 10 11 15
Premises and Equipment, Net
46 43 42 42 42 40 38 36 35 37 51
Goodwill
96 95 95 95 95 95 95 95 95 95 152
Intangible Assets
8.67 6.76 4.96 4.23 3.53 2.84 2.19 1.56 0.97 0.42 43
Other Assets
165 171 171 171 209 271 228 239 237 251 275
Total Liabilities & Shareholders' Equity
3,709 3,864 4,065 4,297 4,430 4,899 5,500 5,672 5,715 5,805 6,975
Total Liabilities
3,346 3,473 3,662 3,862 3,956 4,369 4,959 5,221 5,219 5,274 6,278
Interest Bearing Deposits
2,726 2,829 3,000 3,464 3,538 4,005 4,609 4,827 4,597 4,633 5,538
Short-Term Debt
36 11 11 282 269 162 212 265 486 501 582
Accrued Interest Payable
47 44 50 56 80 117 94 84 92 96 96
Long-Term Debt
536 589 601 59 69 84 44 44 44 44 62
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
363 392 403 436 473 529 541 451 495 531 697
Total Preferred & Common Equity
363 392 403 436 473 529 541 451 495 531 697
Total Common Equity
363 392 403 436 473 529 541 451 495 531 697
Common Stock
153 156 157 158 139 131 123 115 116 116 216
Retained Earnings
222 249 267 302 341 378 424 462 481 509 545
Accumulated Other Comprehensive Income / (Loss)
-12 -14 -20 -24 -6.27 21 -6.23 -126 -102 -95 -64

Quarterly Balance Sheets for Camden National

This table presents Camden National's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
5,552 5,717 5,744 5,780 5,795 5,724 5,745 6,965 6,920 6,982 6,962
Cash and Due from Banks
55 54 51 91 69 79 69 85 98 73 62
Interest Bearing Deposits at Other Banks
27 22 43 120 108 27 70 135 16 26 71
Trading Account Securities
1,262 1,230 1,197 1,143 1,147 1,118 1,135 1,358 1,375 1,390 1,379
Loans and Leases, Net of Allowance
3,824 4,036 4,063 4,022 4,085 4,104 4,081 4,838 4,878 4,957 4,917
Loans and Leases
3,861 4,073 4,100 4,058 4,121 4,139 4,117 4,885 4,931 5,003 4,963
Allowance for Loan and Lease Losses
37 37 37 36 36 35 35 47 53 46 46
Loans Held for Sale
4.63 4,041 12 11 9.52 14 12 11 23 9.78 18
Premises and Equipment, Net
36 36 35 35 35 35 36 53 53 51 51
Goodwill
95 95 95 95 95 95 95 154 152 152 152
Intangible Assets
1.72 1.42 1.27 1.12 0.83 0.69 0.55 47 46 44 41
Other Assets
247 238 246 261 246 252 247 284 280 279 269
Total Liabilities & Shareholders' Equity
5,552 5,717 5,744 5,780 5,795 5,724 5,745 6,965 6,920 6,982 6,962
Total Liabilities
5,121 5,252 5,277 5,316 5,293 5,216 5,215 6,325 6,268 6,305 6,252
Interest Bearing Deposits
4,569 4,643 4,694 4,678 4,552 4,514 4,575 5,597 5,515 5,403 5,585
Short-Term Debt
421 486 448 470 601 553 516 567 599 748 513
Accrued Interest Payable
87 78 90 124 96 105 79 99 92 91 90
Long-Term Debt
44 44 44 44 44 44 44 61 61 62 63
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
431 465 467 463 502 508 530 640 652 676 710
Total Preferred & Common Equity
431 465 467 463 502 508 530 640 652 676 710
Total Common Equity
431 465 467 463 502 508 530 640 652 676 710
Common Stock
115 116 114 115 116 116 116 214 214 215 215
Retained Earnings
453 469 475 479 488 494 501 509 516 530 560
Accumulated Other Comprehensive Income / (Loss)
-136 -119 -122 -130 -103 -101 -87 -82 -78 -68 -65

Annual Metrics And Ratios for Camden National

This table displays calculated financial ratios and metrics derived from Camden National's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
10,204,101.00 15,440,981.00 15,516,049.00 15,584,743.00 15,192,799.00 14,916,644.00 14,849,347.00 - - - 16,922,225.00
DEI Adjusted Shares Outstanding
15,306,151.00 15,440,981.00 15,516,049.00 15,584,743.00 15,192,799.00 14,916,644.00 14,849,347.00 - - - 16,922,225.00
DEI Earnings Per Adjusted Shares Outstanding
1.37 2.59 1.84 3.41 3.77 3.99 4.65 - - - 3.85
Growth Metrics
- - - - - - - - - - -
Revenue Growth
13.22% 34.02% 0.79% 3.03% 7.05% 10.05% 0.20% 0.65% -13.32% 8.39% 44.51%
EBITDA Growth
-9.02% 77.93% 6.02% 3.43% 7.76% 5.73% 16.74% -13.03% -29.28% 18.29% 28.73%
EBIT Growth
-14.30% 86.46% 8.37% 5.49% 8.82% 3.94% 16.46% -11.07% -30.13% 21.59% 20.16%
NOPAT Growth
-14.73% 91.23% -28.93% 86.37% 7.79% 3.99% 16.02% -10.98% -29.39% 22.18% 22.93%
Net Income Growth
-14.73% 91.23% -28.93% 86.37% 7.79% 3.99% 16.02% -10.98% -29.39% 22.18% 22.93%
EPS Growth
-14.73% 48.55% -29.18% 86.26% 8.85% 7.05% 16.46% -9.35% -28.78% 21.89% 6.08%
Operating Cash Flow Growth
-46.74% 260.71% 1.60% 10.29% -48.91% -44.54% 682.86% -26.30% -35.82% -9.74% 4.89%
Free Cash Flow Firm Growth
-154.42% 83.13% 130.68% 5,971.49% -92.00% 307.53% -49.46% 104.51% -325.60% 100.83% -11,044.05%
Invested Capital Growth
13.80% 5.95% 2.39% -23.41% 4.37% -4.34% 2.73% -4.57% 34.73% 4.99% 24.59%
Revenue Q/Q Growth
8.97% 2.39% 0.72% 1.00% 1.87% 6.22% -3.22% -1.12% -4.71% 5.28% 8.70%
EBITDA Q/Q Growth
-11.22% 24.23% 0.50% 1.48% 2.36% 13.30% -7.33% -2.58% -15.51% 16.06% 14.31%
EBIT Q/Q Growth
-16.74% 29.84% 0.86% 2.04% 2.40% 13.79% -7.94% -1.78% -14.36% 14.17% 14.27%
NOPAT Q/Q Growth
-17.34% 29.85% -33.08% 47.74% 2.25% 5.39% -2.52% -1.82% -13.67% 13.21% 13.78%
Net Income Q/Q Growth
-17.34% 29.85% -33.08% 47.74% 2.25% 5.39% -2.52% -1.82% -13.67% 13.21% 13.78%
EPS Q/Q Growth
-17.34% 28.50% -33.58% 46.75% 1.10% 6.18% -2.34% -1.42% -13.66% 13.13% 9.40%
Operating Cash Flow Q/Q Growth
-46.09% 111.32% -12.68% -7.42% 141.04% -24.32% 5.07% -9.14% -32.00% 844.99% -25.98%
Free Cash Flow Firm Q/Q Growth
-449.84% 84.13% 117.12% 79.55% -83.26% 61.36% -40.77% 405.96% -610.63% 102.76% 41.24%
Invested Capital Q/Q Growth
13.63% 4.07% -0.79% -13.34% -0.35% -4.41% -0.58% -15.13% 4.83% -1.32% -9.85%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
33.05% 43.88% 46.16% 46.34% 46.64% 44.81% 52.21% 45.11% 36.81% 40.17% 35.79%
EBIT Margin
27.09% 37.68% 40.52% 41.48% 42.17% 39.83% 46.29% 40.90% 32.97% 36.98% 30.75%
Profit (Net Income) Margin
18.39% 26.24% 18.50% 33.47% 33.70% 31.85% 36.87% 32.61% 26.57% 29.95% 25.48%
Tax Burden Percent
67.90% 69.63% 45.67% 80.68% 79.92% 79.96% 79.66% 79.74% 80.58% 80.97% 82.84%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
32.10% 30.37% 54.33% 19.32% 20.08% 20.04% 20.34% 20.26% 19.42% 19.03% 17.16%
Return on Invested Capital (ROIC)
2.38% 4.16% 2.84% 5.92% 7.20% 7.49% 8.77% 7.89% 4.86% 5.05% 5.39%
ROIC Less NNEP Spread (ROIC-NNEP)
2.38% 4.16% 2.84% 5.92% 7.20% 7.49% 8.77% 7.89% 4.86% 5.05% 5.39%
Return on Net Nonoperating Assets (RNNOA)
4.50% 6.46% 4.33% 6.73% 5.38% 4.37% 4.12% 4.49% 4.31% 5.28% 5.22%
Return on Equity (ROE)
6.89% 10.62% 7.16% 12.65% 12.58% 11.86% 12.89% 12.38% 9.17% 10.33% 10.61%
Cash Return on Invested Capital (CROIC)
-10.52% -1.62% 0.48% 32.43% 2.93% 11.93% 6.08% 12.57% -24.73% 0.17% -16.51%
Operating Return on Assets (OROA)
0.95% 1.52% 1.57% 1.57% 1.64% 1.60% 1.67% 1.38% 0.95% 1.14% 1.23%
Return on Assets (ROA)
0.64% 1.06% 0.72% 1.27% 1.31% 1.28% 1.33% 1.10% 0.76% 0.92% 1.02%
Return on Common Equity (ROCE)
6.89% 10.62% 7.16% 12.65% 12.58% 11.86% 12.89% 12.38% 9.17% 10.33% 10.61%
Return on Equity Simple (ROE_SIMPLE)
5.77% 10.23% 7.06% 12.18% 12.08% 11.24% 12.75% 13.61% 8.76% 9.98% 9.35%
Net Operating Profit after Tax (NOPAT)
21 40 28 53 57 59 69 61 43 53 65
NOPAT Margin
18.39% 26.24% 18.50% 33.47% 33.70% 31.85% 36.87% 32.61% 26.57% 29.95% 25.48%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
44.74% 41.85% 42.81% 43.36% 42.66% 41.37% 43.16% 43.87% 49.64% 48.79% 42.52%
Operating Expenses to Revenue
71.22% 58.87% 57.51% 57.98% 56.15% 53.52% 55.41% 56.72% 65.75% 63.24% 60.53%
Earnings before Interest and Taxes (EBIT)
31 58 62 66 72 74 87 77 54 65 79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
38 67 71 73 79 84 98 85 60 71 92
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.92 1.34 1.27 1.03 1.22 0.86 1.17 1.21 1.05 1.16 1.04
Price to Tangible Book Value (P/TBV)
1.29 1.81 1.68 1.33 1.54 1.06 1.42 1.53 1.30 1.41 1.45
Price to Revenue (P/Rev)
2.94 3.44 3.32 2.83 3.40 2.45 3.38 2.89 3.17 3.49 2.84
Price to Earnings (P/E)
15.97 13.10 17.93 8.46 10.09 7.68 9.16 8.87 11.93 11.64 11.16
Dividend Yield
3.66% 2.35% 2.80% 3.82% 3.16% 4.31% 3.31% 4.28% 4.73% 3.97% 3.91%
Earnings Yield
6.26% 7.63% 5.58% 11.82% 9.92% 13.02% 10.92% 11.28% 8.39% 8.59% 8.96%
Enterprise Value to Invested Capital (EV/IC)
0.88 1.05 1.00 0.93 1.03 0.72 0.84 1.02 0.92 0.88 0.95
Enterprise Value to Revenue (EV/Rev)
7.26 6.79 6.62 4.56 4.94 2.99 3.56 4.13 5.80 5.35 4.98
Enterprise Value to EBITDA (EV/EBITDA)
21.97 15.47 14.35 9.85 10.60 6.67 6.83 9.16 15.76 13.32 13.92
Enterprise Value to EBIT (EV/EBIT)
26.81 18.02 16.34 11.00 11.72 7.50 7.70 10.11 17.60 14.47 16.20
Enterprise Value to NOPAT (EV/NOPAT)
39.49 25.88 35.79 13.63 14.67 9.38 9.67 12.68 21.84 17.87 19.55
Enterprise Value to Operating Cash Flow (EV/OCF)
51.98 18.06 17.47 11.25 25.53 30.61 4.68 7.41 14.04 15.54 19.93
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 212.90 2.49 36.11 5.89 13.94 7.96 0.00 519.47 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.58 1.53 1.52 0.78 0.71 0.47 0.47 0.69 1.07 1.03 0.93
Long-Term Debt to Equity
1.48 1.50 1.49 0.14 0.15 0.16 0.08 0.10 0.09 0.08 0.09
Financial Leverage
1.89 1.55 1.52 1.14 0.75 0.58 0.47 0.57 0.89 1.05 0.97
Leverage Ratio
10.68 10.03 9.97 9.96 9.60 9.30 9.71 11.26 12.03 11.22 10.41
Compound Leverage Factor
10.68 10.03 9.97 9.96 9.60 9.30 9.71 11.26 12.03 11.22 10.41
Debt to Total Capital
61.18% 60.50% 60.25% 43.93% 41.65% 31.80% 32.10% 40.68% 51.70% 50.64% 48.05%
Short-Term Debt to Total Capital
3.84% 1.09% 1.06% 36.34% 33.13% 20.93% 26.54% 34.86% 47.38% 46.52% 43.39%
Long-Term Debt to Total Capital
57.34% 59.41% 59.19% 7.60% 8.51% 10.87% 5.56% 5.83% 4.33% 4.12% 4.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
38.82% 39.50% 39.75% 56.07% 58.35% 68.20% 67.90% 59.32% 48.30% 49.36% 51.95%
Debt to EBITDA
15.20 8.95 8.61 4.65 4.27 2.95 2.62 3.64 8.82 7.66 7.04
Net Debt to EBITDA
13.09 7.64 7.16 3.74 3.31 1.21 0.36 2.75 7.16 4.64 5.97
Long-Term Debt to EBITDA
14.25 8.79 8.46 0.80 0.87 1.01 0.45 0.52 0.74 0.62 0.68
Debt to NOPAT
27.32 14.97 21.47 6.44 5.91 4.15 3.71 5.04 12.22 10.28 9.89
Net Debt to NOPAT
23.52 12.78 17.86 5.17 4.58 1.70 0.51 3.81 9.91 6.23 8.39
Long-Term Debt to NOPAT
25.60 14.70 21.10 1.11 1.21 1.42 0.64 0.72 1.02 0.84 0.96
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-92 -16 4.79 291 23 95 48 98 -221 1.82 -200
Operating Cash Flow to CapEx
499.15% 3,631.75% 2,154.93% 1,505.95% 770.35% 623.03% 7,706.05% 6,125.98% 2,574.68% 1,092.77% 2,534.18%
Free Cash Flow to Firm to Interest Expense
-7.29 -0.94 0.23 9.38 0.57 4.53 4.33 3.90 -2.35 0.02 -1.70
Operating Cash Flow to Interest Expense
1.25 3.47 2.80 2.08 0.80 0.87 12.92 4.19 0.72 0.52 0.54
Operating Cash Flow Less CapEx to Interest Expense
1.00 3.37 2.67 1.94 0.70 0.73 12.75 4.12 0.69 0.47 0.52
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.04
Fixed Asset Turnover
3.26 3.44 3.63 3.76 4.03 4.57 4.82 5.11 4.60 4.91 5.79
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
936 991 1,015 777 811 776 797 761 1,025 1,076 1,341
Invested Capital Turnover
0.13 0.16 0.15 0.18 0.21 0.24 0.24 0.24 0.18 0.17 0.21
Increase / (Decrease) in Invested Capital
113 56 24 -238 34 -35 21 -36 264 51 265
Enterprise Value (EV)
827 1,037 1,019 724 839 558 667 779 947 947 1,274
Market Capitalization
335 525 511 449 577 457 632 545 517 617 727
Book Value per Share
$35.59 $25.36 $26.00 $27.96 $31.16 $35.48 $36.45 $30.98 $34.01 $36.44 $41.16
Tangible Book Value per Share
$25.37 $18.79 $19.58 $21.62 $24.70 $28.95 $29.93 $24.37 $27.43 $29.92 $29.69
Total Capital
936 991 1,015 777 811 776 797 761 1,025 1,076 1,341
Total Debt
572 600 611 342 338 247 256 310 530 545 644
Total Long-Term Debt
536 589 601 59 69 84 44 44 44 44 63
Net Debt
493 512 509 275 262 101 35 234 430 330 547
Capital Expenditures (CapEx)
3.19 1.58 2.71 4.27 4.27 2.93 1.85 1.72 2.62 5.58 2.52
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
572 600 611 342 338 247 256 310 530 545 644
Total Depreciation and Amortization (D&A)
6.80 9.46 8.68 7.70 7.59 9.31 11 7.95 6.28 5.65 13
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.73 $2.59 $1.83 $3.40 $3.70 $3.96 $4.62 $4.18 $2.98 $3.63 $3.86
Adjusted Weighted Average Basic Shares Outstanding
12.03M 15.42M 15.51M 15.57M 15.41M 14.99M 14.90M 14.64M 14.56M 14.58M 16.90M
Adjusted Diluted Earnings per Share
$1.73 $2.57 $1.82 $3.39 $3.69 $3.95 $4.60 $4.17 $2.97 $3.62 $3.84
Adjusted Weighted Average Diluted Shares Outstanding
12.07M 15.50M 15.59M 15.63M 15.45M 15.02M 14.97M 14.70M 14.61M 14.63M 16.98M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.70 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.40M 15.49M 15.54M 15.59M 15.15M 14.91M 14.74M 14.57M 14.57M 16.86M 16.93M
Normalized Net Operating Profit after Tax (NOPAT)
28 41 44 53 57 59 69 61 43 54 73
Normalized NOPAT Margin
24.60% 26.64% 28.36% 33.47% 33.70% 31.85% 36.87% 32.61% 26.57% 30.48% 28.48%
Pre Tax Income Margin
27.09% 37.68% 40.52% 41.48% 42.17% 39.83% 46.29% 40.90% 32.97% 36.98% 30.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.43 3.48 3.00 2.12 1.75 3.56 7.84 3.07 0.57 0.56 0.67
NOPAT to Interest Expense
1.65 2.42 1.37 1.71 1.40 2.85 6.25 2.45 0.46 0.45 0.56
EBIT Less CapEx to Interest Expense
2.18 3.38 2.87 1.99 1.65 3.42 7.67 3.00 0.54 0.51 0.65
NOPAT Less CapEx to Interest Expense
1.40 2.32 1.24 1.58 1.29 2.71 6.08 2.38 0.43 0.41 0.53
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
46.70% 30.93% 50.30% 32.35% 32.47% 33.36% 30.55% 38.27% 56.56% 46.33% 43.70%
Augmented Payout Ratio
46.70% 30.93% 52.43% 33.06% 68.82% 49.64% 45.17% 54.94% 61.17% 49.37% 43.70%

Quarterly Metrics And Ratios for Camden National

This table displays calculated financial ratios and metrics derived from Camden National's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - 16,864,810.00 16,902,160.00 16,920,277.00 16,922,225.00 16,925,329.00
DEI Adjusted Shares Outstanding
- - - - - - 16,864,810.00 16,902,160.00 16,920,277.00 16,922,225.00 16,925,329.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - 0.43 0.83 1.25 1.33 1.29
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-21.17% -17.25% -5.78% 0.07% 19.48% 22.95% 44.38% 45.41% 45.35% 43.04% 7.13%
EBITDA Growth
-22.40% -52.47% 1.05% -5.09% 11.95% 98.45% -50.60% 34.19% 71.65% 57.79% 229.10%
EBIT Growth
-32.88% -46.75% 2.23% -4.40% 31.86% 79.01% -62.20% 19.44% 67.14% 53.37% 354.76%
NOPAT Growth
-31.40% -44.76% 4.28% -3.20% 33.58% 72.95% -44.80% 17.41% 62.12% 53.82% 198.70%
Net Income Growth
-31.40% -44.76% 4.28% -3.20% 33.58% 72.95% -44.80% 17.41% 62.12% 53.82% 198.70%
EPS Growth
-30.93% -44.76% 4.60% -4.71% 34.33% 72.41% -52.75% 2.47% 38.89% 33.00% 200.00%
Operating Cash Flow Growth
210.23% -155.19% 22.34% -15.44% -130.76% 482.30% -94.18% -58.37% 348.89% -51.95% 1,834.82%
Free Cash Flow Firm Growth
10.91% -593.71% 36.52% -56.35% -39.39% 85.72% 17.72% -45.17% -276.65% -563.05% 104.07%
Invested Capital Growth
9.07% 34.73% 15.26% 15.14% 11.54% 4.99% 10.58% 18.79% 36.39% 24.59% 1.36%
Revenue Q/Q Growth
-12.02% 2.76% 7.49% 2.97% 5.05% 5.74% 26.23% 3.70% 5.01% 4.06% -5.46%
EBITDA Q/Q Growth
-9.99% -35.23% 77.43% -8.24% 6.16% 14.81% -55.83% 149.26% 35.80% 5.54% -1.07%
EBIT Q/Q Growth
-22.70% -14.50% 58.90% -8.97% 6.62% 16.07% -66.45% 187.66% 49.20% 6.51% -0.52%
NOPAT Q/Q Growth
-21.00% -13.35% 56.51% -9.64% 9.01% 12.19% -50.05% 92.21% 50.51% 6.44% -3.00%
Net Income Q/Q Growth
-21.00% -13.35% 56.51% -9.64% 9.01% 12.19% -50.05% 92.21% 50.51% 6.44% -3.00%
EPS Q/Q Growth
-21.18% -13.43% 56.90% -10.99% 11.11% 11.11% -57.00% 93.02% 50.60% 6.40% -3.01%
Operating Cash Flow Q/Q Growth
175.21% -123.96% 257.20% -18.41% -200.10% 397.79% -97.61% 483.37% 498.41% -42.51% -3.59%
Free Cash Flow Firm Q/Q Growth
16.11% -257.46% 45.80% 3.80% 25.21% 63.38% -212.33% -69.73% -94.04% 35.54% 101.92%
Invested Capital Q/Q Growth
1.86% 4.83% 11.94% -3.68% -1.33% -1.32% 17.90% 3.48% 13.29% -9.85% -4.02%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
40.97% 25.83% 42.63% 37.99% 38.39% 41.68% 14.59% 35.06% 45.34% 45.98% 48.12%
EBIT Margin
31.93% 26.57% 39.27% 34.72% 35.24% 38.68% 10.28% 28.52% 40.52% 41.47% 43.64%
Profit (Net Income) Margin
25.99% 21.92% 31.91% 28.00% 29.06% 30.83% 12.20% 22.61% 32.41% 33.15% 34.01%
Tax Burden Percent
81.40% 82.49% 81.25% 80.66% 82.46% 79.70% 118.66% 79.28% 79.98% 79.93% 77.94%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
18.60% 17.51% 18.75% 19.34% 17.54% 20.30% -18.66% 20.72% 20.02% 20.07% 22.06%
Return on Invested Capital (ROIC)
4.75% 4.01% 4.79% 4.36% 4.72% 5.19% 1.97% 4.02% 5.92% 7.02% 6.92%
ROIC Less NNEP Spread (ROIC-NNEP)
4.75% 4.01% 4.79% 4.36% 4.72% 5.19% 1.97% 4.02% 5.92% 7.02% 6.92%
Return on Net Nonoperating Assets (RNNOA)
5.21% 3.56% 5.83% 4.87% 5.11% 5.44% 2.20% 4.36% 6.73% 6.80% 6.18%
Return on Equity (ROE)
9.96% 7.56% 10.61% 9.23% 9.84% 10.63% 4.18% 8.37% 12.64% 13.81% 13.10%
Cash Return on Invested Capital (CROIC)
-3.32% -24.73% -10.08% -9.86% -6.38% 0.17% -6.15% -13.11% -26.34% -16.51% 4.89%
Operating Return on Assets (OROA)
0.97% 0.76% 1.10% 0.97% 1.03% 1.19% 0.32% 0.97% 1.50% 1.66% 1.63%
Return on Assets (ROA)
0.79% 0.63% 0.89% 0.79% 0.85% 0.95% 0.37% 0.77% 1.20% 1.33% 1.27%
Return on Common Equity (ROCE)
9.96% 7.56% 10.61% 9.23% 9.84% 10.63% 4.18% 8.37% 12.64% 13.81% 13.10%
Return on Equity Simple (ROE_SIMPLE)
10.85% 0.00% 8.76% 8.56% 8.84% 0.00% 7.35% 7.54% 8.47% 0.00% 11.23%
Net Operating Profit after Tax (NOPAT)
9.79 8.48 13 12 13 15 7.33 14 21 23 22
NOPAT Margin
25.99% 21.92% 31.91% 28.00% 29.06% 30.83% 12.20% 22.61% 32.41% 33.15% 34.01%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
52.93% 54.14% 52.06% 49.22% 48.93% 45.41% 46.64% 42.36% 41.18% 40.33% 42.46%
Operating Expenses to Revenue
69.60% 71.96% 65.78% 63.77% 64.23% 59.62% 74.02% 60.37% 54.94% 54.16% 55.50%
Earnings before Interest and Taxes (EBIT)
12 10 16 15 16 18 6.17 18 26 28 28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
15 9.99 18 16 17 20 8.76 22 30 31 31
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.83 1.05 0.95 0.94 1.13 1.16 1.05 1.04 0.95 1.04 1.12
Price to Tangible Book Value (P/TBV)
1.05 1.30 1.17 1.15 1.37 1.41 1.54 1.49 1.34 1.45 1.54
Price to Revenue (P/Rev)
2.25 3.17 2.96 2.96 3.55 3.49 3.45 3.16 2.74 2.84 3.06
Price to Earnings (P/E)
7.68 11.93 10.83 10.94 12.73 11.64 14.34 13.82 11.28 11.16 9.99
Dividend Yield
6.26% 4.73% 5.14% 5.15% 4.11% 3.97% 4.20% 4.18% 4.40% 3.91% 3.57%
Earnings Yield
13.02% 8.39% 9.23% 9.14% 7.85% 8.59% 6.97% 7.24% 8.87% 8.96% 10.01%
Enterprise Value to Invested Capital (EV/IC)
0.70 0.92 0.82 0.88 0.93 0.88 0.85 0.93 0.91 0.95 0.96
Enterprise Value to Revenue (EV/Rev)
4.02 5.80 5.88 6.02 6.05 5.35 5.55 5.71 5.77 4.98 4.76
Enterprise Value to EBITDA (EV/EBITDA)
9.68 15.76 15.67 16.28 16.60 13.32 17.45 18.11 16.96 13.92 10.95
Enterprise Value to EBIT (EV/EBIT)
10.96 17.60 17.44 18.09 17.74 14.47 19.60 21.07 19.73 16.20 12.32
Enterprise Value to NOPAT (EV/NOPAT)
13.71 21.84 21.51 22.23 21.73 17.87 23.04 24.95 23.71 19.55 15.54
Enterprise Value to Operating Cash Flow (EV/OCF)
6.94 14.04 13.35 14.21 157.77 15.54 24.52 34.30 15.73 19.93 14.95
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 519.47 0.00 0.00 0.00 0.00 19.83
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.11 1.07 1.29 1.17 1.06 1.03 0.98 1.01 1.20 0.93 0.81
Long-Term Debt to Equity
0.10 0.09 0.09 0.09 0.08 0.08 0.10 0.09 0.09 0.09 0.09
Financial Leverage
1.10 0.89 1.22 1.12 1.08 1.05 1.12 1.08 1.14 0.97 0.89
Leverage Ratio
12.67 12.03 11.91 11.75 11.60 11.22 11.18 10.90 10.55 10.41 10.32
Compound Leverage Factor
12.67 12.03 11.91 11.75 11.60 11.22 11.18 10.90 10.55 10.41 10.32
Debt to Total Capital
52.62% 51.70% 56.29% 54.01% 51.41% 50.64% 49.55% 50.33% 54.52% 48.05% 44.79%
Short-Term Debt to Total Capital
48.08% 47.38% 52.42% 50.00% 47.35% 46.52% 44.72% 45.65% 50.32% 43.39% 39.92%
Long-Term Debt to Total Capital
4.53% 4.33% 3.86% 4.01% 4.06% 4.12% 4.83% 4.67% 4.20% 4.66% 4.87%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
47.38% 48.30% 43.71% 45.99% 48.59% 49.36% 50.45% 49.67% 45.48% 51.95% 55.21%
Debt to EBITDA
7.23 8.82 10.71 10.05 9.15 7.66 10.12 9.76 10.13 7.04 5.09
Net Debt to EBITDA
4.26 7.16 7.78 8.27 6.87 4.64 6.59 8.08 8.89 5.97 3.91
Long-Term Debt to EBITDA
0.62 0.74 0.74 0.75 0.72 0.62 0.99 0.91 0.78 0.68 0.55
Debt to NOPAT
10.24 12.22 14.70 13.71 11.98 10.28 13.36 13.44 14.16 9.89 7.23
Net Debt to NOPAT
6.03 9.91 10.68 11.29 9.00 6.23 8.70 11.13 12.43 8.39 5.55
Long-Term Debt to NOPAT
0.88 1.02 1.01 1.02 0.95 0.84 1.30 1.25 1.09 0.96 0.79
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-72 -256 -139 -133 -100 -37 -114 -194 -376 -242 4.64
Operating Cash Flow to CapEx
6,775.14% -1,266.48% 3,258.53% 1,124.92% -847.63% 2,125.39% 58.72% 405.92% 5,238.90% 1,170.99% 1,126.46%
Free Cash Flow to Firm to Interest Expense
-2.85 -9.44 -4.79 -4.45 -3.31 -1.30 -3.86 -6.43 -12.68 -8.61 0.18
Operating Cash Flow to Interest Expense
1.88 -0.42 0.61 0.48 -0.48 1.54 0.04 0.20 1.22 0.74 0.77
Operating Cash Flow Less CapEx to Interest Expense
1.85 -0.45 0.60 0.44 -0.54 1.47 -0.02 0.15 1.20 0.67 0.70
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04
Fixed Asset Turnover
4.81 4.60 4.56 4.57 4.74 4.91 4.44 4.86 5.45 5.79 4.97
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
978 1,025 1,147 1,105 1,091 1,076 1,269 1,313 1,487 1,341 1,286
Invested Capital Turnover
0.18 0.18 0.15 0.16 0.16 0.17 0.16 0.18 0.18 0.21 0.20
Increase / (Decrease) in Invested Capital
81 264 152 145 113 51 121 208 397 265 17
Enterprise Value (EV)
689 947 945 968 1,017 947 1,084 1,226 1,358 1,274 1,239
Market Capitalization
386 517 476 476 596 617 675 679 646 727 797
Book Value per Share
$31.83 $34.01 $34.43 $34.80 $36.36 $36.44 $37.95 $38.58 $39.98 $41.16 $41.95
Tangible Book Value per Share
$25.25 $27.43 $27.87 $28.27 $29.82 $29.92 $26.05 $26.93 $28.42 $29.69 $30.56
Total Capital
978 1,025 1,147 1,105 1,091 1,076 1,269 1,313 1,487 1,341 1,286
Total Debt
514 530 646 597 561 545 629 661 811 644 576
Total Long-Term Debt
44 44 44 44 44 44 61 61 62 63 63
Net Debt
303 430 469 491 421 330 409 547 712 547 442
Capital Expenditures (CapEx)
0.70 0.89 0.55 1.29 1.71 2.03 1.76 1.49 0.69 1.77 1.78
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
514 530 646 597 561 545 629 661 811 644 576
Total Depreciation and Amortization (D&A)
3.41 -0.29 1.40 1.40 1.42 1.43 2.59 4.07 3.15 3.07 2.88
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.67 $0.59 $0.91 $0.82 $0.90 $1.00 $0.43 $0.84 $1.25 $1.34 $1.29
Adjusted Weighted Average Basic Shares Outstanding
14.56M 14.56M 14.57M 14.59M 14.58M 14.58M 16.84M 16.91M 16.92M 16.90M 16.92M
Adjusted Diluted Earnings per Share
$0.67 $0.58 $0.91 $0.81 $0.90 $1.00 $0.43 $0.83 $1.25 $1.33 $1.29
Adjusted Weighted Average Diluted Shares Outstanding
14.60M 14.61M 14.63M 14.65M 14.65M 14.63M 16.93M 16.97M 17.01M 16.98M 17.02M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
14.56M 14.57M 14.61M 14.57M 14.58M 16.86M 16.90M 16.92M 16.92M 16.93M 16.91M
Normalized Net Operating Profit after Tax (NOPAT)
9.79 8.48 13 12 14 15 9.59 15 21 23 22
Normalized NOPAT Margin
25.99% 21.92% 31.91% 28.00% 30.39% 30.83% 15.97% 24.40% 32.79% 33.20% 34.01%
Pre Tax Income Margin
31.93% 26.57% 39.27% 34.72% 35.24% 38.68% 10.28% 28.52% 40.52% 41.47% 43.64%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.48 0.38 0.57 0.50 0.53 0.66 0.21 0.59 0.89 1.00 1.08
NOPAT to Interest Expense
0.39 0.31 0.46 0.40 0.43 0.52 0.25 0.47 0.72 0.80 0.84
EBIT Less CapEx to Interest Expense
0.45 0.35 0.55 0.45 0.47 0.58 0.15 0.54 0.87 0.94 1.01
NOPAT Less CapEx to Interest Expense
0.36 0.28 0.44 0.36 0.38 0.45 0.19 0.42 0.69 0.74 0.77
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
48.25% 56.56% 55.86% 56.37% 52.43% 46.33% 54.23% 53.90% 47.99% 43.70% 35.76%
Augmented Payout Ratio
52.77% 61.17% 60.41% 60.01% 55.94% 49.37% 57.65% 53.83% 47.93% 43.70% 37.62%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways for Camden National (CAC) based on the latest quarterly data and the prior four years of results. The focus is on revenue, earnings, cash flow, and balance-sheet trends that matter to retail investors.

  • Revenue and profitability improved in 2025 quarters: Q4 2025 Total Revenue reached $68.052 million with Net Income from continuing operations of $22.159 million. Basic EPS was $1.34 and Diluted EPS $1.33, up meaningfully from Q4 2024 where Total Revenue was $46.764 million, Net Income from continuing operations was $14.666 million, and Basic Diluted EPS were about $0.84/$0.83.
  • Net interest income trending higher in 2025: Net interest income rose to $53.918 million in Q4 2025, up from $48.858 million in Q1 2025, signaling improved interest income generation or margins across the year.
  • Deposit base expanding as a funding source: Net Change in Deposits was about $134.97 million in Q4 2025, indicating a growing core deposit base that supports funding stability.
  • Earnings per share momentum improving: Q4 2025 Basic EPS of $1.34 and Diluted EPS of $1.33 compare favorably to prior-year levels (Q4 2024 Basic EPS ~$0.84, Diluted ~$0.83), reflecting stronger quarterly profitability per share.
  • Lending portfolio remains sizeable and steady: Loans and Leases net of allowance stood around $4.95 billion in late-2025 (e.g., Q3 2025: $4.957 billion), suggesting ongoing loan growth and scale in the balance sheet.
  • Credit provisioning showed volatility early in 2025: Provision for loan losses peaked early in 2025 (Q1 2025: $9.429 million) and remained elevated relative to late-2024, signaling some credit headwinds during the year.
05/09/26 05:31 PM ETAI Generated. May Contain Errors.

Camden National Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Camden National's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Camden National's net income appears to be on an upward trend, with a most recent value of $65.16 million in 2025, rising from $20.95 million in 2015. The previous period was $53.00 million in 2024. See Camden National's forecast for analyst expectations on what's next for the company.

Over the last 10 years, Camden National's total revenue changed from $113.93 million in 2015 to $255.78 million in 2025, a change of 124.5%.

Camden National's total liabilities were at $6.28 billion at the end of 2025, a 19.0% increase from 2024, and a 87.6% increase since 2015.

In the past 10 years, Camden National's cash and equivalents has ranged from $38.90 million in 2021 to $79.49 million in 2015, and is currently $71.50 million as of their latest financial filing in 2025.

Over the last 10 years, Camden National's book value per share changed from 35.59 in 2015 to 41.16 in 2025, a change of 15.6%.



Financial statements for NASDAQ:CAC last updated on 5/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners